Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
79.64
+1.16 (1.48%)
At close: Dec 5, 2025, 4:00 PM EST
79.89
+0.25 (0.31%)
After-hours: Dec 5, 2025, 7:54 PM EST
Revolution Medicines Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 15,396 | 8,083 | 4,720 | 2,115 | 1,855 | 2,628 | |
| Market Cap Growth | 68.74% | 71.26% | 123.15% | 14.03% | -29.43% | - | |
| Enterprise Value | 13,879 | 6,620 | 3,969 | 1,525 | 1,278 | 2,195 | |
| Last Close Price | 79.64 | 43.74 | 28.68 | 23.82 | 25.17 | 39.59 | |
| PS Ratio | - | - | 407.58 | 59.78 | 63.11 | 61.14 | |
| PB Ratio | 9.46 | 3.57 | 2.58 | 3.09 | 3.08 | 5.54 | |
| P/TBV Ratio | 10.09 | 3.68 | 2.69 | 3.46 | 3.51 | 6.58 | |
| EV/Sales Ratio | - | - | 342.78 | 43.11 | 43.48 | 51.07 | |
| Debt / Equity Ratio | 0.26 | 0.06 | 0.05 | 0.09 | 0.11 | 0.07 | |
| Asset Turnover | - | - | 0.01 | 0.05 | 0.05 | 0.11 | |
| Quick Ratio | 7.86 | 13.97 | 12.89 | 10.48 | 9.66 | 9.48 | |
| Current Ratio | 8.05 | 14.20 | 13.06 | 10.65 | 9.77 | 9.63 | |
| Return on Equity (ROE) | -60.76% | -29.33% | -34.75% | -38.63% | -34.73% | -34.49% | |
| Return on Assets (ROA) | -32.29% | -18.66% | -20.08% | -20.83% | -18.00% | -17.56% | |
| Return on Capital (ROIC) | -35.37% | -19.97% | -21.67% | -22.76% | -19.98% | -20.96% | |
| Return on Capital Employed (ROCE) | -51.70% | -28.80% | -24.10% | -34.40% | -27.70% | -21.30% | |
| Earnings Yield | -6.24% | -7.42% | -9.25% | -11.76% | -10.09% | -4.12% | |
| FCF Yield | -5.05% | -7.02% | -7.59% | -11.12% | -8.29% | -3.92% | |
| Buyback Yield / Dilution | -15.98% | -48.24% | -40.34% | -10.74% | -32.68% | -1879.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.